Bnp Paribas Asset Management Holding S.A. Moderna, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 73,198 shares of MRNA stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
73,198
Previous 85,473
14.36%
Holding current value
$2.28 Million
Previous $5.71 Million
46.73%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding MRNA
# of Institutions
926Shares Held
252MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.25 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.21 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$795 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$547 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$227 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...